Melatonin is also found to have SERM (selective estrogen receptor modulators) and SEEM (selective estrogen enzyme modulators) properties thus potentially can be used as adjuvant therapy for estrogen-positive breast cancer [33]. Here, ESR1 is linked to breast cancer.